Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias

Leukemia

Volumn 20, Issue 11, 2006, Pages 1963-1966

  Palomero, T ^a,b   McKenna, K ^c   O Neil, J ^c   Galinsky, I ^c   Stone, R ^c   Suzukawa, K ^d   Stiakaki, E ^e   Kalmanti, M ^e   Fox, E A ^c   Caligiuri, M A ^f   Aster, J C ^g   Look, A T ^c   Ferrando, A A ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e UNIVERSITY OF CRETE   (Greece)

^f OHIO STATE UNIVERSITY   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH1 RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOLECULAR CLONING; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAMPLE; STEM CELL; T CELL LEUKEMIA; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 33750306240     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404409     Document Type: Article

References (19)

1. Weng AP, Ferrando AA, Lee W, Morris JPT, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269-271.
2. Das I, Craig C, Funahashi Y, Jung KM, Kim TW, Byers R et al. Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function. J Biol Chem 2004; 279: 30771-30780.
3. Wong GT, Manfra D, Poulet FM, Zhang Q, Josien H, Bara T et al. Chronic treatment with the gamma-secretase inhibitor LY-411575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem 2004; 279: 12876-12882.
4. Li L, Milner LA, Deng Y, Iwata M, Banta A, Graf L et al. The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 1998; 8: 43-55.
5. Varnum-Finney B, Purton LE, Yu M, Brashem-Stein C, Flowers D, Staats S et al. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood 1998; 91: 4084-4091.
6. Moore KA, Pytowski B, Witte L, Hicklin D, Lemischka IR. Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc Natl Acad Sci USA 1997; 94: 4011-4016.
7. Milner LA, Bigas A, Kopan R, Brashem-Stein C, Bernstein ID, Martin DI. Inhibition of granulocytic differentiation by mNotch1. Proc Natl Acad Sci USA 1956; 93: 13014-13019.
8. Jones P, May G, Healy L, Brown J, Hoyne G, Delassus S et al. Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. Blood 1998; 92: 1505-1511.
9. Walker L, Lynch M, Silverman S, Fraser J, Boulter J, Weinmaster G et al. The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro. Stem Cells 1999; 17: 162-171.
10. Han W, Ye Q, Moore MA. A soluble form of human delta-like-1 inhibits differentiation of hematopoietic progenitor cells. Blood 2000; 95: 1616-1625.
11. Carlesso N, Aster JC, Sklar J, Scadden DT. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood 1999; 93: 838-848.
12. Schroeder T, Kohlhof H, Rieber N, Just U. Notch signaling induces multilineage myeloid differentiation and up-regulates PU.1 expression. J Immunol 2003; 170: 5538-5548.
13. Drexler HG, Gaedicke G, Maeda S, Chen PM, Minowada J. Monocytoid leukemia cell line CTV-1: Morphological, immunological and isoenzymatic characteristics. Tumour Biol 1986; 6: 503-517.
14. Chen P, Chiu C, Chiou T, Maeda S, Chiang H, Tzeng C et al. Establishment and characterization of a human monocytoid leukemia cell line, CTV-1. Gann 1984; 75: 660-664.
15. Herrmann R, Han T, Barcos MP, Lok MS, Henderson ES. Malignant lymphoma of pre-T-cell type terminating in acute myelocytic leukemia. A case report with enzymic and immunologic marker studies. Cancer 1980; 46: 1383-1388.
16. Ohyashiki K, Ohyashiki JH, Sandberg AA. Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ML-1, -2, and -3): origin of the cells. Cancer Res 1986; 46: 3642-3647.
17. Tanabe S, Zeleznik-Le NJ, Kobayashi H, Vignon C, Espinosa III R, LeBeau MM et al. Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line. Genes Chromosomes Cancer 1996; 15: 206-216.
18. Tanigaki K, Tsuji M, Yamamoto N, Han H, Tsukada J, Inoue H et al. Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity 2004; 20: 611-622.
19. Mantadakis E, Danilatou V, Stiakaki E, Paterakis G, Papadhimitriou S, Kalmanti M. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia. Pediatr Blood Cancer (in press).